1. Home
  2. IZEA vs ICCC Comparison

IZEA vs ICCC Comparison

Compare IZEA & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IZEA
  • ICCC
  • Stock Information
  • Founded
  • IZEA 2006
  • ICCC 1982
  • Country
  • IZEA United States
  • ICCC United States
  • Employees
  • IZEA N/A
  • ICCC N/A
  • Industry
  • IZEA Advertising
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • IZEA Consumer Discretionary
  • ICCC Health Care
  • Exchange
  • IZEA Nasdaq
  • ICCC Nasdaq
  • Market Cap
  • IZEA 29.1M
  • ICCC 60.1M
  • IPO Year
  • IZEA N/A
  • ICCC 1987
  • Fundamental
  • Price
  • IZEA $2.57
  • ICCC $6.74
  • Analyst Decision
  • IZEA
  • ICCC
  • Analyst Count
  • IZEA 0
  • ICCC 0
  • Target Price
  • IZEA N/A
  • ICCC N/A
  • AVG Volume (30 Days)
  • IZEA 38.5K
  • ICCC 41.6K
  • Earning Date
  • IZEA 08-13-2025
  • ICCC 08-12-2025
  • Dividend Yield
  • IZEA N/A
  • ICCC N/A
  • EPS Growth
  • IZEA N/A
  • ICCC N/A
  • EPS
  • IZEA N/A
  • ICCC N/A
  • Revenue
  • IZEA $36,896,490.00
  • ICCC $27,302,766.00
  • Revenue This Year
  • IZEA $22.24
  • ICCC N/A
  • Revenue Next Year
  • IZEA N/A
  • ICCC N/A
  • P/E Ratio
  • IZEA N/A
  • ICCC N/A
  • Revenue Growth
  • IZEA 7.17
  • ICCC 28.29
  • 52 Week Low
  • IZEA $1.68
  • ICCC $3.34
  • 52 Week High
  • IZEA $3.15
  • ICCC $7.60
  • Technical
  • Relative Strength Index (RSI)
  • IZEA 44.91
  • ICCC 54.25
  • Support Level
  • IZEA $2.56
  • ICCC $6.21
  • Resistance Level
  • IZEA $2.71
  • ICCC $6.86
  • Average True Range (ATR)
  • IZEA 0.13
  • ICCC 0.64
  • MACD
  • IZEA -0.02
  • ICCC -0.04
  • Stochastic Oscillator
  • IZEA 20.06
  • ICCC 58.87

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: